MAPT and Alzheimer disease: Therefore, the evidence provided in the current study suggests that the plaque microenvironment in AsymAD individuals does not facilitate the formation of soluble tau species with strong seeding activity, unlike in neurotoxic tau oligomers formation in AD brains [60].